| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 22 Jul 2024 | 15 Jul 2024 |
| Solara Active Pharma Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/07/2024 inter alia to consider and approve unaudited financial results for the quarter ended June 30 2024. | ||
| Board Meeting | 29 May 2024 | 21 May 2024 |
| Solara Active Pharma Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 inter alia to consider and approve audited financial results (standalone and consolidated) of the Company for the quarter and year ended March 31 2024. Results for the period ended March 31, 2024 Outcome of Board Meeting (As Per BSE Announcement Dated on 29.05.2024) | ||
| Board Meeting | 14 Feb 2024 | 5 Feb 2024 |
| Solara Active Pharma Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve unaudited financial results for the period ended December 31 2023 Unaudited Financial Results for the period ended December 31, 2023 Resignation of Mr. P V Raghavendra Rao from the position of Chief Financial Officer of the Company from the close of business hours of February 15, 2024. Appointment of Mr. M Mohan as Executive Director of the Company with effect from February 14, 2024. (As Per BSE Announcement Dated on 14/02/2024) | ||
| Board Meeting | 14 Nov 2023 | 7 Nov 2023 |
| Solara Active Pharma Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2023 inter alia to consider and approve unaudited Financial Results for the period ended September 30 2023. Unaudited Financial Results for the quarter ended September 30, 2023 We hereby inform you that based on the recommendations of the Nomination & Remuneration Committee, the Board of Directors of the Company has appointed Mr. Rajendra Kumar Srivastava as Additional Non-Executive Independent Director and Mr. Rajiv Vijay Nabar as Additional Non- Executive Non-Independent Director of the Company with effect from November 14, 2023. (As per BSE Announcement Dated on 14/11/2023) | ||
| Board Meeting | 19 Oct 2023 | 19 Oct 2023 |
| In accordance with SEBI (LODR), Regulations, 2015, it is hereby informed that the Board in its meeting held today has approved the appointment of Mr. P.V Raghavendra Rao as Chief Financial Officer of the Company and designated him as KMP with effect from October 26, 2023. | ||
| Board Meeting | 14 Aug 2023 | 4 Aug 2023 |
| Solara Active Pharma Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2023 inter alia to consider and approve the un-audited financial results (standalone and consolidated) of the Company for the quarter ended June 30 2023 amongst other matters. The Board Meeting to be held on 11/08/2023 has been revised to 14/08/2023 The Board Meeting to be held on 11/08/2023 has been revised to 14/08/2023 (As per BSE Announcement Dated on 07/08/2023) Pursuant to Regulation 30 of SEBI (LODR), this is to inform you that Board of Directors at their meeting held today (August 14, 2023) have approved and reconstituted the composition of Audit Committee, Risk Mangement Committee and Corporate Social Responsibility Committee. (As Per BSE Announcement Dated on 14.08.2023) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
